Gonococcal infection of lower genitourinary tract, unspecified
ICD-10 A54.2 is a billable code used to indicate a diagnosis of gonococcal infection of lower genitourinary tract, unspecified.
Gonococcal infection of the lower genitourinary tract is caused by the bacterium Neisseria gonorrhoeae, a sexually transmitted infection (STI) that primarily affects the urethra in men and the cervix in women. Symptoms may include dysuria, increased urinary frequency, and purulent discharge. In women, it can lead to pelvic inflammatory disease (PID) if left untreated. The infection is often asymptomatic, particularly in women, which can lead to delayed diagnosis and treatment. Gonococcal infections can also be transmitted to newborns during childbirth, leading to conjunctivitis. Diagnosis is typically made through nucleic acid amplification tests (NAATs) or culture methods. Treatment usually involves dual therapy with antibiotics, such as ceftriaxone and azithromycin, to combat potential antibiotic resistance. Contact tracing is crucial to prevent further transmission, as partners of infected individuals should be notified and tested. Regular screening is recommended for sexually active individuals, particularly those with multiple partners or those in high-risk groups.
Detailed patient history, including sexual history and symptoms.
Diagnosis and management of STIs, treatment of gonococcal infections.
Consideration of antibiotic resistance patterns in treatment.
Documentation of pelvic exams, symptoms, and treatment plans.
Screening and treatment of gonorrhea in pregnant women.
Importance of screening during pregnancy to prevent neonatal transmission.
Used for diagnosing gonococcal infections in symptomatic patients.
Document the reason for testing and patient symptoms.
Infectious disease specialists may require additional lab results.
Common symptoms include dysuria, purulent discharge, and pelvic pain. However, many individuals may be asymptomatic.
Treatment typically involves dual antibiotic therapy, often with ceftriaxone and azithromycin, to address potential resistance.
Contact tracing helps prevent further transmission of the infection by ensuring that partners are tested and treated.
